Jeena Sikho Lifecare Ltd

Jeena Sikho Lifecare Ltd

₹ 1,175 -1.15%
24 May - close price
About

Jeena Sikho Lifecare is one of the leading ayurvedic healthcare system providers in India. The company is providing healthcare services for the last ten years.

Key Points

Leading Ayurveda Company
Jeena Sikho Lifecare is a developing healthcare product & services provider in India. The company has a portfolio of a wide range of Ayurvedic products. The company also conducts various health checkup camps, and yoga sessions free of cost to make people aware of their health problems. [1]

  • Market Cap 2,921 Cr.
  • Current Price 1,175
  • High / Low 1,227 / 178
  • Stock P/E 42.2
  • Book Value 77.3
  • Dividend Yield 0.09 %
  • ROCE 74.5 %
  • ROE 55.0 %
  • Face Value 10.0

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has delivered good profit growth of 63.1% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 47.7%

Cons

  • Stock is trading at 15.2 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Half Yearly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Sep 2021 Mar 2022 Sep 2022 Mar 2023 Sep 2023 Mar 2024
79 71 75 86 117 157 167
70 62 66 70 88 112 119
Operating Profit 9 9 9 16 30 45 48
OPM % 12% 13% 12% 19% 25% 29% 29%
0 1 0 1 1 1 5
Interest 1 1 1 1 0 0 0
Depreciation 1 1 2 1 2 2 3
Profit before tax 8 8 7 15 29 44 50
Tax % 29% 26% 26% 27% 23% 27% 26%
6 6 5 11 23 32 37
EPS in Rs 280.00 3.42 2.78 4.50 9.05 12.78 15.04
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
106 94 136 146 204 324
95 84 119 128 158 231
Operating Profit 11 11 17 18 46 93
OPM % 10% 11% 13% 12% 23% 29%
0 1 1 1 2 6
Interest 1 2 1 1 1 0
Depreciation 1 2 2 3 3 5
Profit before tax 8 8 14 15 45 94
Tax % 28% 26% 27% 26% 24% 26%
6 6 10 11 34 69
EPS in Rs 300.00 286.50 514.50 6.19 13.55 27.84
Dividend Payout % 0% 0% 0% 0% 8% 15%
Compounded Sales Growth
10 Years: %
5 Years: 25%
3 Years: 34%
TTM: 59%
Compounded Profit Growth
10 Years: %
5 Years: 63%
3 Years: 88%
TTM: 108%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 535%
Return on Equity
10 Years: %
5 Years: 48%
3 Years: 48%
Last Year: 55%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 0 0 0 10 14 25
Reserves 8 14 24 26 112 167
16 12 12 7 1 1
12 12 13 18 24 28
Total Liabilities 36 38 49 62 151 221
13 17 23 28 60 67
CWIP 0 0 0 5 1 4
Investments 0 0 0 0 5 4
23 21 26 28 86 146
Total Assets 36 38 49 62 151 221

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
1 12 18 17 17 37
-11 -6 -8 -20 -36 -18
7 -5 -2 -5 48 -3
Net Cash Flow -2 1 8 -7 29 15

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 15 17 9 22 40
Inventory Days 204 315 208 136 87
Days Payable 125 168 73 109 129
Cash Conversion Cycle 94 163 143 49 -2
Working Capital Days 35 30 13 6 29
ROCE % 38% 50% 39% 53%

Shareholding Pattern

Numbers in percentages

1 Recently
Apr 2022Sep 2022Mar 2023Sep 2023Nov 2023Mar 2024
65.89% 65.89% 66.20% 67.91% 67.91% 67.91%
0.00% 0.00% 0.00% 2.00% 1.79% 0.26%
0.00% 0.00% 0.00% 0.04% 0.00% 0.00%
34.11% 34.11% 33.80% 30.05% 30.30% 31.83%
No. of Shareholders 1,9518346638151,1072,721

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

No data available.

Concalls